Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
GLP-1 Receptor Activation Modulates Appetite- and Reward-related Brain Areas in Humans Diabetes 63(12) 2014PMID: 24953787 PubMed 6 Rubino D, Abrahamsson N, Davies M, et al
Compared with placebo, a significant decrease in HbA1c with both dosages (1.45% and 1.55% for 0.5 mg and 1.0 mg, respectively) was observed in SUSTAIN 1
Thirteen patients experienced a reduction in prostate-specific antigen (PSA) Levels, And disease stabilization was observed in 11, showing a strong correlation between immune activation and early clinical benefit ( P = 0.002, r = 0.68)
This product is not intended to diagnose, treat, cure, or prevent any disease." This is the standard regulatory framing for all dietary supplements in the United States, and buyers should understand that FDA "not evaluated" status applies to virtually every supplement on the market - it reflects the regulatory category, not a specific quality or efficacy finding about this product
